Gene · 129607
Papers1,751
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,751
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PharmGKB summary: acyclovir/ganciclovir pathway. | Pharmacogenet Genomics | 2022 | 35665708 | PubTator, text mining | PubMed |
| The interplay between lncRNAs, RNA-binding proteins and viral genome during SARS-CoV-2 infection reveals strong connections with regulatory events involved in RNA metabolism and immune response. | Theranostics | 2022 | 35664076 | PubTator, text mining | PubMed |
| Identification of candidate biomarkers and pathways associated with type 1 diabetes mellitus using bioinformatics analysis. | Sci Rep | 2022 | 35650387 | PubTator, text mining | PubMed |
| Immune-and Metabolism-Associated Molecular Classification of Ovarian Cancer. | Front Oncol | 2022 | 35646692 | PubTator, text mining | PubMed |
| A Role for the Chicken Interferon-Stimulated Gene CMPK2 in the Host Response Against Virus Infection. | Front Microbiol | 2022 | 35633731 | PubTator, text mining | PubMed |
| An In-Vitro Study of the Expansion and Transcriptomics of CD4+ and CD8+ Naïve and Memory T Cells Stimulated by IL-2, IL-7 and IL-15. | Cells | 2022 | 35626739 | PubTator, text mining | PubMed |
| miR-18a Mediates Immune Evasion in ER-Positive Breast Cancer through Wnt Signaling. | Cells | 2022 | 35626709 | PubTator, text mining | PubMed |
| Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review. | Cancers (Basel) | 2022 | 35626089 | PubTator, text mining | PubMed |
| Immune-Related Protein Interaction Network in Severe COVID-19 Patients toward the Identification of Key Proteins and Drug Repurposing. | Biomolecules | 2022 | 35625619 | PubTator, text mining | PubMed |
| G-Quadruplex-Binding Proteins: Promising Targets for Drug Design. | Biomolecules | 2022 | 35625576 | PubTator, text mining | PubMed |
| The Metabolic Activation of Sofosbuvir Is Impaired in an Experimental Model of NAFLD. | Biology (Basel) | 2022 | 35625421 | PubTator, text mining | PubMed |
| Protein interaction networks in neurodegenerative diseases: From physiological function to aggregation. | J Biol Chem | 2022 | 35623389 | PubTator, text mining | PubMed |
| Gene Expression Profiles of Treatment Response and Non-Response in Children With Juvenile Dermatomyositis. | ACR Open Rheumatol | 2022 | 35616642 | PubTator, text mining | PubMed |
| Precision Oncology: Artificial Intelligence and DNA Methylation Analysis of Circulating Cell-Free DNA for Lung Cancer Detection. | Front Oncol | 2022 | 35600397 | PubTator, text mining | PubMed |
| Improved Interpretation of Protein Conformational Differences and Ligand Occupancy in Large-Scale Cross-Link Data. | J Proteome Res | 2022 | 35594376 | PubTator, text mining | PubMed |
| Characterization of uridine-cytidine kinase like-1 nucleoside kinase activity and its role in tumor growth. | Biochem J | 2022 | 35583288 | PubTator, text mining | PubMed |
| Fundamental aspects of long-acting tenofovir alafenamide delivery from subdermal implants for HIV prophylaxis. | Sci Rep | 2022 | 35581262 | PubTator, text mining | PubMed |
| Fluorescent Indicators For Biological Imaging of Monatomic Ions. | Front Cell Dev Biol | 2022 | 35573682 | PubTator, text mining | PubMed |
| Interaction Between Non-Coding RNAs and Interferons: With an Especial Focus on Type I Interferons. | Front Immunol | 2022 | 35572537 | PubTator, text mining | PubMed |
| Anti-POSTN and Anti-TIMP1 Autoantibodies as Diagnostic Markers in Esophageal Squamous Cell Carcinoma. | Front Genet | 2022 | 35559040 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/129607/papers?page=19